Annual report pursuant to Section 13 and 15(d)

Ocular Therapeutix License Agreement (Details Narrative)

v3.23.1
Ocular Therapeutix License Agreement (Details Narrative)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Ocular Therapeutix License Agreement  
Reimbursement fees $ 50,000